ArticleExperimental and therapeutic medicine2026
Efficacy of opioids in combination with gabapentin vs. opioids alone in the treatment of patients with cancer-related pain due to bone metastases from malignant neoplasms: A meta-analysis.
Article in Experimental and therapeutic medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer pain seriously affects the quality of life of patients with malignant tumors, especially the pain caused by bone metastases. In recent years, gabapentin has demonstrated potential value in the treatment of cancer pain from bone metastases, providing promising new ideas for clinical treatment. The aim of the present study was to systematically evaluate the efficacy of opioids combined with gabapentin compared with opioids alone in the treatment of cancer-related pain due to bone metastases of malignant tumors based on meta-analysis. PubMed, Embase, Web of Science, China National Knowledge Infrastructure, VIP, Wanfang Data and other databases were searched to collect randomized controlled trials and non-randomized controlled trials of opioids combined with gabapentin compared with opioids alone for the treatment of cancer pain due to malignant bone metastases. The quality of the included studies was evaluated using the Cochrane Risk of Bias Assessment 2.0 tool and the Newcastle-Ottawa Scale. Subsequent meta-analyses were performed using the R language. A total of 25 studies including 1,805 patients were included. Meta-analysis results showed that gabapentin in combination with opioids exhibited a notable advantage in reducing pain scores compared with opioids alone (mean difference=1.26; 95% CI, 0.88-1.65). Subgroup analyses by study type, sample size and treatment regimen revealed that heterogeneity was influenced by a number of factors. Sensitivity analyses demonstrated the robustness of the findings. However, limited data on adverse effects precluded comprehensive safety analysis. Gabapentin in combination with opioids may be an effective regimen for the treatment of cancer-related pain associated with bone metastases from malignant tumors. However, due to the heterogeneity of the included studies and limited safety data, clinical application requires caution and individualized treatment regimens based on patient-specific conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.